{
    "nctId": "NCT02802644",
    "officialTitle": "A Prospective, Multi-center, Randomized, Controlled Study to Evaluate the Effect of DiPeptidyl-Peptidase 4 Inhibitor on Vascular Healing After Biodegradable Polymer Based Sirolimus Eluting Stent Implantation in Diabetic Patients: OCT Study (DIAMOND-OCT)",
    "inclusionCriteria": "* Non-ST segement elevation acute coronary syndrome\n* Must have minimum age of 20 Years",
    "exclusionCriteria": "* Left main disease\n* Known hypersensitivity or contraindication to any of the following medications: Heparin, aspirin, clopidogrel, sirolimus, siptagliptin and statin\n* Congestive heart failure (patients with LVEF \\<30% or cardiogenic shock)\n* Uncontrolled myocardial ischemia (repeated chest pain or dyspnea after revascularization)\n* Uncontrolled ventricular arrhythmia\n* History of malignancy with chemotherapy\n* Serious hematologic disease (e.g. CML, MDS)\n* Current infectious disease needs antibiotics therapy\n* Creatinine level \\>1.5 mg/dL or dependence on dialysis\n* Other severe concurrent illness (e.g. active infection, malignancy).\n* Life expectancy of less than one year\n* Pregnancy or women with potential childbearing\n* Type I DM\n* Treatment with insulin\n* History of pancreatitis\n* Who cannot read the informed consent form (e.g. illiteracy, foreigner)"
}